Genetic mutations predict patient response to immunotherapy
Saturday, June 10, 2017 - 15:22
in Health & Medicine
Results of a new clinical study establish particular genetic defects in tumors as clinical indicators for successful response to a type of immunotherapy called PD-1 blockade.